DHS COVID-19 PROVIDER GUIDANCE // ODP
ODP Announcement 20-065: Clarification Reporting Cases of COVID-19
Issued: June 4, 2020
All Qualified Providers,
Supports Coordination Organizations (SCOs) providing services through the
Consolidated, Person/Family Directed Support and Community Living (ID/A) Waivers
and the Adult Autism Waiver (AAW),
Administrative Entities (AEs),
Adult Community Autism Program (ACAP),
Private Intermediate Care Facilities for Individuals with Intellectual Disabilities (ICF/IDs)
To provide supplemental guidance to stakeholders regarding reporting cases of COVID19 to the Office of Developmental Programs (ODP) for individuals registered or enrolled
and staff. This guidance is supplemental to ODP Announcement 20-049 UPDATE issued
on April 30, 2020 and provides clarification as testing standards and best-practices continue
As testing for COVID-19 has become more available in Pennsylvania and the possibility
of universal testing is becoming a viable option, ODP is providing additional clarification
regarding reporting requirements for individuals and staff.
Any time an individual or staff is tested for COVID-19 and receives a positive test result;
individual testing must be reported. This reporting is required, regardless of the reason
for the test. Reporting should continue for individuals or staff who are suspected to
have COVID-19 due to the presence of symptoms and are tested.
|Reporting for individuals and staff is not required when testing occurs and the results are negative as a result of the following:|
In addition, antibody testing is not required to be reported for individuals or staff.
Symptoms of COVID-19 include, but are not limited to:
- Fever or chills
- Shortness of breath or difficulty breathing
- Muscle or body aches
- New loss of taste or smell
- Sore throat
- Congestion or runny nose
- Nausea or vomiting
- In addition to the typical symptoms of COVID-19as identified by the Centers for
Disease Control (CDC), ODP providers have noted that for individuals with ID/A,
COVID-19 infection has caused muscle aches, weakness or a change in baseline
behavior without or prior to respiratory symptoms emerging. Providers should
closely observe individuals for weakness or other changes in behavior that may
be indicative of illness.
For additional guidance regarding the reporting of COVID-19 testing, please review ODP
Announcement 20-049 (Update) issued on 4/30/2020.